Medical News

RSS

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients (4 months to 16 years of age) at high risk of developing CMV disease.

31 Aug 2009

High incidence of HIV infection is found among South African gays

New research from UCSF examining HIV among men who have sex with men (MSM) in the township of Soweto in South Africa has found that a third of gay-identified men are infected with HIV.

31 Aug 2009

People who drink alcohol are likely to exercise more than teetotalers

Drinkers aren't just bending their elbows: according to a new study, the more alcohol people drink, the more likely they might be to exercise.

31 Aug 2009

RE-LY trial establishes effectiveness of PRADAX in reducing stroke risk in AF patients

Results of the landmark RE-LY(R) Trial (Randomized Evaluation of Long term anticoagulant therapy) demonstrate that atrial fibrillation (AF) patients taking PRADAX(R) (dabigatran etexilate) 150mg twice daily (BID) significantly reduced their risk of stroke and systemic embolism by 34 per cent (p less than 0.001) as compared to patients well-controlled on warfarin, without increasing the risk of major bleeding.

31 Aug 2009

Grupo Televisa and Genomma Lab announces their alliance agreement

Grupo Televisa, S.A.B. and Genomma Lab Internacional, S.A.B. de C.V. announced today that they have signed a strategic alliance agreement to sell and distribute personal care and over the counter pharmaceuticals in the United States and Puerto Rico.

31 Aug 2009

Oral dabigatran etexilate reduces the risk of stroke and systemic embolism

Boehringer Ingelheim today announced data from the landmark RE-LY® study - the largest atrial fibrillation (AF) outcomes trial ever conducted (18,113 patients in 44 countries worldwide) - presented for the first time at the European Society of Cardiology Congress and published online in the New England Journal of Medicine. Results show that dabigatran etexilate 150mg BID significantly reduces the risk of stroke and systemic embolism by 34% (p<0.001) in patients with atrial fibrillation compared to well-controlled warfarin without increasing the risk of major bleeding.

31 Aug 2009

HHS Flu Prevention PSA contest conducted to help promote flu prevention

Help us select a winner! It’s time for the public to vote for the best video in the HHS Flu Prevention Public Service Announcement (PSA) Contest. The producer of the winning video gets a $2,500 cash award, and the winning PSA will be broadcast on national television!

30 Aug 2009

New sleep formula unveiled at USANA Health Sciences' 17th annual international convention

USANA Health Sciences, Inc. hosted thousands of independent Associates and guests from around the world this week for its 17th annual international convention in Salt Lake City.

30 Aug 2009

Intermediate dosages of otamixaban reduce acute coronary complications

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.

30 Aug 2009

Clinical data of the REVERSE trial reveals how CRT improves functioning of the heart

Cardiac resynchronization therapy (CRT) is a proven therapy indicated for patients with moderate to severe heart failure. Additional 24-month clinical data presented today on the European cohort of 262 patients in the REVERSE (Resynchronization Reverse Remodeling in Systolic Left Ventricular Dysfunction) trial, sponsored by Medtronic, Inc., provides a deeper understanding of how CRT improves the function of the heart, including reduction in heart size and improvements in pumping efficiency, in certain heart failure patients with mild symptoms.

30 Aug 2009

Initial results of the CURRENT-OASIS 7 clinical trial due for release

Today, the OASIS study group will present initial results of the CURRENT-OASIS 7 clinical trial at the European Society of Cardiology congress in Barcelona. Sanofi-aventis and Bristol-Myers Squibb, co-commercialization and co-development partners for PLAVIX(clopidogrel bisulfate), were sponsors of the study.

30 Aug 2009

Caltech neuroscientists emphasize on the neural mechanisms involved in social behaviour

In a finding that sheds new light on the neural mechanisms involved in social behavior, neuroscientists at the California Institute of Technology (Caltech) have pinpointed the brain structure responsible for our sense of personal space.

30 Aug 2009

New molecular sensor could identify zinc-related diseases

Scientists have developed a new molecular sensor that can reveal the amount of zinc in cells, which could tell us more about a number of diseases, including type 2 diabetes. The research, published today in Nature Methods, opens the door to the hidden world of zinc biology by giving scientists an accurate way of measuring the concentration of zinc and its location in cells for the first time.

30 Aug 2009

As Kennedy is memorialized, talk turns to impact on health legislation

"The left claims the Senate's liberal champion would have settled for nothing less than universal care and a new government-run insurance option. Republican foes of those ideas say the Democrats should take a lesson from Kennedy's gift for cutting a pragmatic deal and sacrifice some of their priorities in the interest of a bargain the GOP could support."

30 Aug 2009

GOP finance negotiators cast doubts on bipartisan health bill

The Associated Press: "A leading GOP negotiator on health care struck a further blow to fading chances of a bipartisan compromise by saying Democratic proposals would restrict medical choices and make the country's 'finances sicker without saving you money.' ... In the Republicans' weekly radio and Internet address on Saturday, [Sen. Mike] Enzi, D-Wyo., said any health care legislation must lower medical costs for Americans without increasing deficits and the national debt. 'The bills introduced by congressional Democrats fail to meet these standards,' he said."

30 Aug 2009

Emotions still running high in health care reform debate

In the first, NPR notes: Conservative political activists associated with the so-called 'Tea Party' protests have started a cross-country bus convoy dubbed the Tea Party Express. They plan to stop in 33 cities. Tea Party Express organizer Mark Williams, also a conservative talk show host, said there is a lot of dissatisfaction in the country right now focused on issues from health care reform to the national debt.

30 Aug 2009

“Next Top Doc” quiz winner to receive the ReachMD $5000.00 Educational Scholarship

ReachMD LLC and ReachMD XM Radio 160, a leading multi-media provider of advanced healthcare education and information, teamed with Dr. Nancy Snyderman, Chief Medical Editor of NBC News, and on staff in the Department of Otolaryngology-Head and Neck Surgery at the University of Pennsylvania, to present the winner of “ReachMD’s Next Top Doc” quiz show with the ReachMD $5000.00 Educational Scholarship.

29 Aug 2009

Food guide application for iPhone/iPod users impacted by celiac/coeliac disease and food allergies

The iPhone(TM)/iPod(R) touch application, iCanEat OnTheGo Gluten & Allergen Free(TM), expands the suite of innovative solutions to help those impacted by celiac/coeliac disease, food allergies or intolerances safely eat out anywhere.

29 Aug 2009

NASDAQ issues Staff Determination letter to Hythiam

Hythiam, Inc. (NASDAQ:HYTM) today announced that on August 28, 2009 Hythiam, Inc. (the “Company”) received a letter (the “Staff Determination”) from the Nasdaq Stock Market (“NASDAQ”) notifying the Company that, based upon the Company’s non-compliance with the $10 million stockholders’ equity requirement set forth in NASDAQ Listing Rule 5450(b) as of August 27, 2009, the Company’s securities were subject to delisting from The NASDAQ Global Market unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (the “NASDAQ Panel”).

29 Aug 2009

Scientists explore the fundamental basis of the lateral-line sensory system

Fish and some amphibians possess a unique sensory capability in the so-called lateral-line system. It allows them, in effect, to "touch" objects in their surroundings without direct physical contact or to "see" in the dark. Professor Leo van Hermmen and his team in the physics department of the Technische Universitaet Muenchen are exploring the fundamental basis for this sensory system. What they discover might one day, through biomimetic engineering, better equip robots to orient themselves in their environments.

29 Aug 2009